Search bioRxiv⌕ Search

Biology subjects

Chiou, L. F.

Publications and source records attributed to Chiou, L. F..

2 recordsLinked to original sources

The RING Finger E3 Ligase RNF25 Protects DNA Replication Forks Independently of its Canonical Roles in Ubiquitin Signaling

The DNA damage response (DDR) mechanisms that allow cells to tolerate DNA replication stress are critically important for genome stability and cell viability. Using an unbiased genetic screen we identify a role for the RING finger E3 ubiquitin ligase RNF25 in promoting DNA replication stress tolerance. In response to DNA replication stress, RNF25-deficient cells generate aberrantly high levels of single-stranded DNA (ssDNA), accumulate in S-phase and show reduced mitotic entry. Using single-molecule DNA fiber analysis, we show that RNF25 protects reversed DNA replication forks generated by the fork remodeler HLTF from nucleolytic degradation by MRE11 and CtIP. Mechanistically, RNF25 interacts with the replication fork protection factor REV7 and recruits REV7 to nascent DNA after replication stress. The role of RNF25 in protecting replication forks is fully separable from its canonical functions in ubiquitin conjugation. This work reveals the RNF25-REV7 signaling axis as an important protective mechanism in cells experiencing replication stress.

molecular biology↗

CD73 restrains mutant β-catenin oncogenic activity in endometrial carcinomas

Missense mutations in exon 3 of CTNNB1, the gene encoding {beta}-catenin, are associated with poor outcomes in endometrial carcinomas (EC). Clinically, CTNNB1 mutation status has been difficult to use as a predictive biomarker as {beta}-catenin oncogenic activity is modified by other factors, and these determinants are unknown. Here we reveal that CD73 restrains the oncogenic activity of exon 3 {beta}-catenin mutants, and its loss associates with recurrence. Using 7 patient-specific mutants, with genetic deletion or ectopic expression of CD73, we show that CD73 loss increases {beta}-catenin-TCF/LEF transcriptional activity. In cells lacking CD73, membrane levels of mutant {beta}-catenin decreased which corresponded with increased levels of nuclear and chromatin-bound mutant {beta}-catenin. These results suggest CD73 sequesters mutant {beta}-catenin to the membrane to limit its oncogenic activity. Adenosine A1 receptor deletion phenocopied increased {beta}-catenin-TCF/LEF activity seen with NT5E deletion, suggesting that the effect of CD73 loss on mutant {beta}-catenin is mediated via attenuation of adenosine receptor signaling. RNA-seq analyses revealed that NT5E deletion alone drives pro-tumor Wnt/{beta}-catenin gene expression and, with CD73 loss, {beta}-catenin mutants dysregulate zinc-finger and non-coding RNA gene expression. We identify CD73 as a novel regulator of oncogenic {beta}-catenin and help explain variability in patient outcomes in CTNNB1 mutant EC. O_FIG O_LINKSMALLFIG WIDTH=178 HEIGHT=200 SRC="FIGDIR/small/624183v1_ufig1.gif" ALT="Figure 1"> View larger version (54K): org.highwire.dtl.DTLVardef@f8e8f0org.highwire.dtl.DTLVardef@184e92aorg.highwire.dtl.DTLVardef@e7cb55org.highwire.dtl.DTLVardef@1d6421e_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical AbstractC_FLOATNO C_FIG

cancer biology↗